These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27519492)

  • 1. Long-Term Nicergoline Treatment of Mild to Moderate Senile Dementia : Results of a Multicentre, Double-Blind, Placebo-Controlled Study.
    Nappi G; Bono G; Merlo P; Borromei A; Caltagirone C; Lomeo C; Martucci N; Fabbrini G; Annoni K; Battaglia A
    Clin Drug Investig; 1997 Jun; 13(6):308-16. PubMed ID: 27519492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
    Battaglia A; Bruni G; Ardia A; Sacchetti G
    J Am Geriatr Soc; 1989 Apr; 37(4):295-302. PubMed ID: 2646350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of organic brain syndrome with nicergoline given once a day].
    Ladurner G; Erhart P; Erhart C; Scheiber V
    Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 24-month, double-blind, placebo-controlled multicentre pilot study of the efficacy and safety of nicergoline 60 mg per day in elderly hypertensive patients with leukoaraiosis.
    Bès A; Orgogozo JM; Poncet M; Rancurel G; Weber M; Bertholom N; Calvez R; Stehlé B
    Eur J Neurol; 1999 May; 6(3):313-22. PubMed ID: 10210912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K
    Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Pentoxifylline Multi-Infarct Dementia Study.
    Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contingent negative variation and reaction time in patients with presenile idiopathic cognitive decline and presenile Alzheimer-type dementia. Preliminary report on long-term nicergoline treatment.
    Zappoli R; Arnetoli G; Paganini M; Versari A; Battaglia A; Grignani A; Sacchetti G
    Neuropsychobiology; 1987; 18(3):149-54. PubMed ID: 3453431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ergoloids and ischaemic strokes; efficacy and mechanism of action.
    Elwan O; Helmy AA; Tamawy ME; Naseer MA; Banhawy IE; Kader AA; Elwan F
    J Int Med Res; 1995; 23(3):154-66. PubMed ID: 7649339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R; Erbler H
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry.
    Schneider F; Popa R; Mihalas G; Stefanigă P; Mihalas IG; Măties R; Mateescu R
    Ann N Y Acad Sci; 1994 Jun; 717():332-42. PubMed ID: 8030850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group.
    Filip V; Kolibás E
    J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.